Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.

Clinical therapeutics

Volumn 32, Issue 1, 2010, Pages 179-192

  Vaz da Silva, Manuel ^a   Almeida, Luis ^a   Falcão, Amilcar ^a   Soares, Eva ^a   Maia, Joana ^a   Nunes, Teresa ^a   Soares da Silva, Patricio ^a  

^a DEPARTMENT OF RESEARCH AND DEVELOPMENT   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DIBENZAZEPINE DERIVATIVE; ESLICARBAZEPINE ACETATE; SODIUM CHANNEL BLOCKING AGENT; WARFARIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD; BLOOD CLOTTING; CLINICAL TRIAL; DELAYED RELEASE FORMULATION; DOSE RESPONSE; DRUG EFFECT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; METHODOLOGY; TANDEM MASS SPECTROMETRY; TIME;

ADULT; ANTICOAGULANTS; AREA UNDER CURVE; BLOOD COAGULATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DIBENZAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; SODIUM CHANNEL BLOCKERS; TANDEM MASS SPECTROMETRY; TIME FACTORS; WARFARIN; YOUNG ADULT;

MLCS; MLOWN;

EID: 77952294567     PISSN: None     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.01.014     Document Type: Article

References (0)